Back

Randomized comparisons of the platelet inhibitory effect of clopidogrel and low dose of ticagrelor in patients receiving antiplatelet therapy after percutaneous coronary intervention

29 August 2016 (12:21 - 12:30)
Organised by:
Congress Presentation Part of: Clinical studies on platelet inhibition Thrombosis and platelets ESC Premium Access ESC Congress 2016

About the speaker

Photo
Associate Professor Han-Young Jin

Busan Paik Hospital, Busan (Korea (Republic of))

9 More presentations in this session

Presentation thumbnail
Incidence of colorectal cancer in new users and non-users of low-dose aspirin for primary prevention of cardiovascular or cerebrovascular disease in the United Kingdom
Doctor L. Garcia Rodriguez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the Credo-Kyoto registry cohort-2
Doctor M. Natsuaki (Saga, JP)
Abstract Slides Video
Presentation thumbnail
Clinical implications of low-dose aspirin in vasospastic angina : the 3-year prognosis
Doctor Y. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Validation of the DAPT score in the all comer PRODIGY trial
Doctor R. Piccolo (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Aspirin desensitization in patients with coronary artery disease: results of a multicenter registry
Doctor R. Rossini (Cuneo, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical studies on platelet inhibition

The Event

Event poster

ESC Congress 2016

29 August 2016 12:21 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources